CORCEPT THERAPEUTICS INC - COM (CORT)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
90.9 M
Holdings value Q1 2024
$2.29 B
Value change Q1 2024
+$175 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
274
Number of buys Q1 2024
152
Number of sells Q1 2024
-128
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
218352102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 90.9 M $2.29 B +$175 M $25.19 274
2023 Q4 83.4 M $2.71 B +$86.2 M $32.48 270
2023 Q3 82.1 M $2.24 B +$50.5 M $27.25 242
2023 Q2 80.5 M $1.79 B -$140 M $22.25 218
2023 Q1 86.9 M $1.88 B +$89.8 M $21.66 232
2022 Q4 83.3 M $1.69 B -$55.2 M $20.31 238
2022 Q3 85.3 M $2.19 B +$74.8 M $25.64 219
2022 Q2 83.5 M $1.96 B +$67.6 M $23.78 206
2022 Q1 81 M $1.83 B +$18.3 M $22.52 207
2021 Q4 80.5 M $1.59 B -$6.67 M $19.80 199
2021 Q3 80.8 M $1.59 B +$5.51 M $19.68 197
2021 Q2 80.4 M $1.77 B -$29.8 M $22.00 194
2021 Q1 81.3 M $1.93 B -$39.9 M $23.79 205
2020 Q4 81.7 M $2.14 B -$132 M $26.16 216
2020 Q3 89.2 M $1.55 B +$5.23 M $17.40 215
2020 Q2 89.6 M $1.51 B +$28.4 M $16.82 217
2020 Q1 85.9 M $1.02 B -$19.9 M $11.89 189
2019 Q4 89 M $1.08 B +$45.5 M $12.10 200
2019 Q3 84 M $1.19 B +$2.45 M $14.13 186
2019 Q2 85.8 M $956 M +$2.16 M $11.15 174
2019 Q1 86.9 M $1.02 B -$45.4 M $11.74 198
2018 Q4 90.5 M $1.21 B +$18.9 M $13.36 206
2018 Q3 89.6 M $1.26 B +$21.6 M $14.02 202
2018 Q2 87 M $1.37 B +$15.7 M $15.72 212
2018 Q1 86.5 M $1.42 B -$23.3 M $16.45 206
2017 Q4 88.6 M $1.6 B +$259 M $18.06 181
2017 Q3 73.8 M $1.42 B +$85.4 M $19.30 191
2017 Q2 69.6 M $822 M +$109 M $11.80 153
2017 Q1 60.7 M $665 M +$148 M $10.96 133
2016 Q4 53.3 M $387 M +$44.1 M $7.26 137
2016 Q3 47.2 M $307 M +$9.9 M $6.50 111
2016 Q2 45.7 M $250 M +$14.8 M $5.46 109
2016 Q1 33.9 M $158 M -$1.02 M $4.68 95
2015 Q4 34.1 M $170 M -$118 K $4.98 95
2015 Q3 34.2 M $129 M +$5.2 M $3.76 94
2015 Q2 31.9 M $192 M +$11.9 M $6.01 78
2015 Q1 30.3 M $170 M +$9.77 M $5.60 60
2014 Q4 28.6 M $85.9 M -$1.42 M $3.00 49
2014 Q3 29.3 M $78.6 M -$1.07 M $2.68 53
2014 Q2 29.7 M $83.2 M -$5.49 M $2.80 60
2014 Q1 30.4 M $133 M +$11.1 M $4.36 58